BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 4905154)

  • 1. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 2. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.
    Tallal L; Tan C; Oettgen H; Wollner N; McCarthy M; Helson L; Burchenal J; Karnofsky D; Murphy ML
    Cancer; 1970 Feb; 25(2):306-20. PubMed ID: 4905155
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 5. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
    Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
    [No Abstract]   [Full Text] [Related]  

  • 6. L-asparaginase.
    Capizzi RL; Bertino JR; Handschumacher RE
    Annu Rev Med; 1970; 21():433-44. PubMed ID: 4913953
    [No Abstract]   [Full Text] [Related]  

  • 7. A summary of the clinical status of asparaginase.
    Burchenal JH
    Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R; Dolowy WC
    Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
    [No Abstract]   [Full Text] [Related]  

  • 11. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

  • 12. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and pharmacological studies with asparaginase in man.
    Ohnuma T; Holland JF; Freeman A; Sinks LF
    Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of malignant human neoplasms with L-asparaginase].
    Oettgen HF; Schulten HK
    Klin Wochenschr; 1969 Jan; 47(2):65-71. PubMed ID: 4904782
    [No Abstract]   [Full Text] [Related]  

  • 17. L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.
    Hill JM; Roberts J; Loeb E; Khan A; MacLellan A; Hill RW
    JAMA; 1967 Nov; 202(9):882-8. PubMed ID: 5234350
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA; Wada JK; Patch MJ; McGehee W
    Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 20. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
    Cridland MD
    Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.